Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil

Detalhes bibliográficos
Autor(a) principal: Paula Bruno Monteiro
Data de Publicação: 2016
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Biblioteca Digital de Teses e Dissertações da UFC
Texto Completo: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=17484
Resumo: Cervical cancer was responsible for the death of 265,000 women in the world in 2012. With the exception of skin cancer, this tumor is the one with the greatest potential for prevention and cure when diagnosed early. The conventional Pap test (Papanicolaou) is the main strategy of screening programs for cervical cancer in Brazil and worldwide. It is known that, in developing countries, many women only seek health services when they show symptoms of disease or during pregnancy. Therefore, pregnancy can be a good opportunity to conduct a Pap smear with the aim of preventing cervical cancer. This study had the objective of assess the dynamics of offering and performing cytology collection for screening cervical cancer in pregnant women in Fortaleza-CE. This is a descriptive cross-sectional study with a quantitative approach. The research was conducted at the Maternity School Assis Chateaubriand (MEAC), with a sample of 318 patients. Univariate and multivariate analysis was performed using SPSS statistical software. Only 11% of all patients and 10.8% of patients over 25 years took advantage of the prenatal consultations to make the Pap smear. Among the 283 (89%) patients who did not realize cervical cancer prevention in pregnancy, the majority, 80.9%, did not do it because the health professional had not offered. In the analysis of demographic and socioeconomic variables, the group of patients who were employed at the time showed the highest prevalence of taking the exam during pregnancy compared to women who did not work (PR: 2.19; 95% CI 1.00 to 4.87; p: 0.043). Patients that had the pregnancy considered high risk pregnancy (PR: 3.15; 95% CI 1.52 to 6.54; p <0.001), that had prenatal care at MEAC (PR: 2.77; 95% CI 1.48 -5.19; p 0.001), that made all consultations with a physician (PR: 2.95; 95% CI 1.53 to 5.69; p: 0.003), that did not have a health center close to home (PR: 3.22; 95% CI 1.44 to 7.21; p: 0.026) and that knew that the exam could be done during pregnancy (PR: 5.05; 95% CI 2.16 to 11.83; p <0.001) had significantly higher prevalence of having their Pap smear performed during prenatal care. It can be concluded that the frequency of offering and the realization of cervical cytological collection was very low and that it is necessary to conduct awareness programs for health professionals on the importance and safety of performing the prevention of cervical cancer during prenatal visits
id UFC_2bbeff4e37b2853b0513e404c675b0e8
oai_identifier_str oai:www.teses.ufc.br:11223
network_acronym_str UFC
network_name_str Biblioteca Digital de Teses e Dissertações da UFC
spelling info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisDynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara BrasilDinÃmica de oferecimento e realizaÃÃo da citologia em gestante de Fortaleza2016-02-24Francisco HerlÃnio Costa Carvalho44307110382http://buscatextual.cnpq.br/buscatextual/visualizacv.jsp?id=K4775406T6Luciano Lima Correia10503862304Josà EleutÃrio JÃnior2112640232064234185353http://lattes.cnpq.br/6668018235314472Paula Bruno MonteiroUniversidade Federal do CearÃPrograma de PÃs-GraduaÃÃo em SaÃde PÃblicaUFCBRSAUDE COLETIVACervical cancer was responsible for the death of 265,000 women in the world in 2012. With the exception of skin cancer, this tumor is the one with the greatest potential for prevention and cure when diagnosed early. The conventional Pap test (Papanicolaou) is the main strategy of screening programs for cervical cancer in Brazil and worldwide. It is known that, in developing countries, many women only seek health services when they show symptoms of disease or during pregnancy. Therefore, pregnancy can be a good opportunity to conduct a Pap smear with the aim of preventing cervical cancer. This study had the objective of assess the dynamics of offering and performing cytology collection for screening cervical cancer in pregnant women in Fortaleza-CE. This is a descriptive cross-sectional study with a quantitative approach. The research was conducted at the Maternity School Assis Chateaubriand (MEAC), with a sample of 318 patients. Univariate and multivariate analysis was performed using SPSS statistical software. Only 11% of all patients and 10.8% of patients over 25 years took advantage of the prenatal consultations to make the Pap smear. Among the 283 (89%) patients who did not realize cervical cancer prevention in pregnancy, the majority, 80.9%, did not do it because the health professional had not offered. In the analysis of demographic and socioeconomic variables, the group of patients who were employed at the time showed the highest prevalence of taking the exam during pregnancy compared to women who did not work (PR: 2.19; 95% CI 1.00 to 4.87; p: 0.043). Patients that had the pregnancy considered high risk pregnancy (PR: 3.15; 95% CI 1.52 to 6.54; p <0.001), that had prenatal care at MEAC (PR: 2.77; 95% CI 1.48 -5.19; p 0.001), that made all consultations with a physician (PR: 2.95; 95% CI 1.53 to 5.69; p: 0.003), that did not have a health center close to home (PR: 3.22; 95% CI 1.44 to 7.21; p: 0.026) and that knew that the exam could be done during pregnancy (PR: 5.05; 95% CI 2.16 to 11.83; p <0.001) had significantly higher prevalence of having their Pap smear performed during prenatal care. It can be concluded that the frequency of offering and the realization of cervical cytological collection was very low and that it is necessary to conduct awareness programs for health professionals on the importance and safety of performing the prevention of cervical cancer during prenatal visitsO cÃncer de colo uterino foi responsÃvel pelo Ãbito de 265 mil mulheres no mundo em 2012. Com exceÃÃo do cÃncer de pele, esse tumor à o que apresenta maior potencial de prevenÃÃo e cura, quando diagnosticado precocemente. O teste citopatolÃgico convencional (Papanicolaou) à a principal estratÃgia de programas de rastreamento do cÃncer do colo do Ãtero no Brasil e no mundo. Sabe-se que, em paÃses em desenvolvimento, muitas mulheres sà procuram os ServiÃos de SaÃde quando apresentam sintomas de doenÃas ou durante a gravidez. Portanto, a gravidez pode ser uma boa oportunidade de realizar uma colpocitologia com o objetivo de prevenÃÃo do cÃncer do colo uterino. O presente estudo teve o objetivo de avaliar a dinÃmica de oferecimento e realizaÃÃo de coleta de citologia oncÃtica para rastreamento de cÃncer de colo uterino em gestantes em Fortaleza-CE. Trata-se de um estudo descritivo de abordagem quantitativa do tipo transversal. A pesquisa foi desenvolvida na Maternidade Escola Assis Chateaubriand, com amostra de 318 pacientes. Para anÃlise univariada e bivariada foi utilizado o programa estatÃstico SPSS. Apenas 11% das pacientes aproveitaram as consultas prÃ-natais para realizar o exame citopatolÃgico do colo do Ãtero. Entre as 283 (89%) pacientes que nÃo realizaram sua prevenÃÃo de cÃncer de colo uterino na gestaÃÃo, a grande maioria, 80,9% nÃo o fez devido o profissional de saÃde nÃo ter oferecido. Na anÃlise das variÃveis demogrÃficas e socioeconÃmicas, o grupo de pacientes que exerciam atividade remunerada apresentou prevalÃncia maior, estatisticamente significante, de realizar o exame durante a gravidez quando comparadas Ãs mulheres que nÃo trabalhavam (RP: 2,19; IC95%1,00-4,87; p: 0,043). Pacientes cuja gravidez foi considerada de alto risco (RP: 3,15; IC95%1,52-6,54; p<0,001), que fizeram o prÃ-natal na MEAC (RP: 2,77; IC95% 1,48-5,19; p0,001), que realizaram todas as consultas com mÃdico (RP: 2,95; IC95% 1,53-5,69; p: 0,003), nÃo ter posto de saÃde perto de casa (RP: 3,22; IC95% 1,44-7,21; p: 0,026) e consciÃncia do nÃo risco da coleta durante a gestaÃÃo (RP: 5,05; IC95% 2,16-11,83; p < 0,001) apresentaram prevalÃncia significativamente maior de terem seu exame citopatolÃgico realizado durante o prÃ-natal. Pode-se concluir que a frequÃncia de oferecimento e realizaÃÃo da coleta colpocitolÃgica à muito baixa e que à necessÃrio realizar programas de conscientizaÃÃo dos profissionais de saÃde da importÃncia e seguranÃa da realizaÃÃo da prevenÃÃo do cÃncer de colo uterino durante as consultas prÃ-natais.CoordenaÃÃo de AperfeÃoamento de Pessoal de NÃvel Superior http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=17484application/pdfinfo:eu-repo/semantics/openAccessporreponame:Biblioteca Digital de Teses e Dissertações da UFCinstname:Universidade Federal do Cearáinstacron:UFC2019-01-21T11:30:50Zmail@mail.com -
dc.title.en.fl_str_mv Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
dc.title.alternative.pt.fl_str_mv DinÃmica de oferecimento e realizaÃÃo da citologia em gestante de Fortaleza
title Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
spellingShingle Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
Paula Bruno Monteiro
SAUDE COLETIVA
title_short Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
title_full Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
title_fullStr Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
title_full_unstemmed Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
title_sort Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
author Paula Bruno Monteiro
author_facet Paula Bruno Monteiro
author_role author
dc.contributor.advisor1.fl_str_mv Francisco HerlÃnio Costa Carvalho
dc.contributor.advisor1ID.fl_str_mv 44307110382
dc.contributor.advisor1Lattes.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.jsp?id=K4775406T6
dc.contributor.referee1.fl_str_mv Luciano Lima Correia
dc.contributor.referee1ID.fl_str_mv 10503862304
dc.contributor.referee2.fl_str_mv Josà EleutÃrio JÃnior
dc.contributor.referee2ID.fl_str_mv 21126402320
dc.contributor.authorID.fl_str_mv 64234185353
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/6668018235314472
dc.contributor.author.fl_str_mv Paula Bruno Monteiro
contributor_str_mv Francisco HerlÃnio Costa Carvalho
Luciano Lima Correia
Josà EleutÃrio JÃnior
dc.subject.cnpq.fl_str_mv SAUDE COLETIVA
topic SAUDE COLETIVA
dc.description.sponsorship.fl_txt_mv CoordenaÃÃo de AperfeÃoamento de Pessoal de NÃvel Superior
dc.description.abstract.por.fl_txt_mv Cervical cancer was responsible for the death of 265,000 women in the world in 2012. With the exception of skin cancer, this tumor is the one with the greatest potential for prevention and cure when diagnosed early. The conventional Pap test (Papanicolaou) is the main strategy of screening programs for cervical cancer in Brazil and worldwide. It is known that, in developing countries, many women only seek health services when they show symptoms of disease or during pregnancy. Therefore, pregnancy can be a good opportunity to conduct a Pap smear with the aim of preventing cervical cancer. This study had the objective of assess the dynamics of offering and performing cytology collection for screening cervical cancer in pregnant women in Fortaleza-CE. This is a descriptive cross-sectional study with a quantitative approach. The research was conducted at the Maternity School Assis Chateaubriand (MEAC), with a sample of 318 patients. Univariate and multivariate analysis was performed using SPSS statistical software. Only 11% of all patients and 10.8% of patients over 25 years took advantage of the prenatal consultations to make the Pap smear. Among the 283 (89%) patients who did not realize cervical cancer prevention in pregnancy, the majority, 80.9%, did not do it because the health professional had not offered. In the analysis of demographic and socioeconomic variables, the group of patients who were employed at the time showed the highest prevalence of taking the exam during pregnancy compared to women who did not work (PR: 2.19; 95% CI 1.00 to 4.87; p: 0.043). Patients that had the pregnancy considered high risk pregnancy (PR: 3.15; 95% CI 1.52 to 6.54; p <0.001), that had prenatal care at MEAC (PR: 2.77; 95% CI 1.48 -5.19; p 0.001), that made all consultations with a physician (PR: 2.95; 95% CI 1.53 to 5.69; p: 0.003), that did not have a health center close to home (PR: 3.22; 95% CI 1.44 to 7.21; p: 0.026) and that knew that the exam could be done during pregnancy (PR: 5.05; 95% CI 2.16 to 11.83; p <0.001) had significantly higher prevalence of having their Pap smear performed during prenatal care. It can be concluded that the frequency of offering and the realization of cervical cytological collection was very low and that it is necessary to conduct awareness programs for health professionals on the importance and safety of performing the prevention of cervical cancer during prenatal visits
O cÃncer de colo uterino foi responsÃvel pelo Ãbito de 265 mil mulheres no mundo em 2012. Com exceÃÃo do cÃncer de pele, esse tumor à o que apresenta maior potencial de prevenÃÃo e cura, quando diagnosticado precocemente. O teste citopatolÃgico convencional (Papanicolaou) à a principal estratÃgia de programas de rastreamento do cÃncer do colo do Ãtero no Brasil e no mundo. Sabe-se que, em paÃses em desenvolvimento, muitas mulheres sà procuram os ServiÃos de SaÃde quando apresentam sintomas de doenÃas ou durante a gravidez. Portanto, a gravidez pode ser uma boa oportunidade de realizar uma colpocitologia com o objetivo de prevenÃÃo do cÃncer do colo uterino. O presente estudo teve o objetivo de avaliar a dinÃmica de oferecimento e realizaÃÃo de coleta de citologia oncÃtica para rastreamento de cÃncer de colo uterino em gestantes em Fortaleza-CE. Trata-se de um estudo descritivo de abordagem quantitativa do tipo transversal. A pesquisa foi desenvolvida na Maternidade Escola Assis Chateaubriand, com amostra de 318 pacientes. Para anÃlise univariada e bivariada foi utilizado o programa estatÃstico SPSS. Apenas 11% das pacientes aproveitaram as consultas prÃ-natais para realizar o exame citopatolÃgico do colo do Ãtero. Entre as 283 (89%) pacientes que nÃo realizaram sua prevenÃÃo de cÃncer de colo uterino na gestaÃÃo, a grande maioria, 80,9% nÃo o fez devido o profissional de saÃde nÃo ter oferecido. Na anÃlise das variÃveis demogrÃficas e socioeconÃmicas, o grupo de pacientes que exerciam atividade remunerada apresentou prevalÃncia maior, estatisticamente significante, de realizar o exame durante a gravidez quando comparadas Ãs mulheres que nÃo trabalhavam (RP: 2,19; IC95%1,00-4,87; p: 0,043). Pacientes cuja gravidez foi considerada de alto risco (RP: 3,15; IC95%1,52-6,54; p<0,001), que fizeram o prÃ-natal na MEAC (RP: 2,77; IC95% 1,48-5,19; p0,001), que realizaram todas as consultas com mÃdico (RP: 2,95; IC95% 1,53-5,69; p: 0,003), nÃo ter posto de saÃde perto de casa (RP: 3,22; IC95% 1,44-7,21; p: 0,026) e consciÃncia do nÃo risco da coleta durante a gestaÃÃo (RP: 5,05; IC95% 2,16-11,83; p < 0,001) apresentaram prevalÃncia significativamente maior de terem seu exame citopatolÃgico realizado durante o prÃ-natal. Pode-se concluir que a frequÃncia de oferecimento e realizaÃÃo da coleta colpocitolÃgica à muito baixa e que à necessÃrio realizar programas de conscientizaÃÃo dos profissionais de saÃde da importÃncia e seguranÃa da realizaÃÃo da prevenÃÃo do cÃncer de colo uterino durante as consultas prÃ-natais.
description Cervical cancer was responsible for the death of 265,000 women in the world in 2012. With the exception of skin cancer, this tumor is the one with the greatest potential for prevention and cure when diagnosed early. The conventional Pap test (Papanicolaou) is the main strategy of screening programs for cervical cancer in Brazil and worldwide. It is known that, in developing countries, many women only seek health services when they show symptoms of disease or during pregnancy. Therefore, pregnancy can be a good opportunity to conduct a Pap smear with the aim of preventing cervical cancer. This study had the objective of assess the dynamics of offering and performing cytology collection for screening cervical cancer in pregnant women in Fortaleza-CE. This is a descriptive cross-sectional study with a quantitative approach. The research was conducted at the Maternity School Assis Chateaubriand (MEAC), with a sample of 318 patients. Univariate and multivariate analysis was performed using SPSS statistical software. Only 11% of all patients and 10.8% of patients over 25 years took advantage of the prenatal consultations to make the Pap smear. Among the 283 (89%) patients who did not realize cervical cancer prevention in pregnancy, the majority, 80.9%, did not do it because the health professional had not offered. In the analysis of demographic and socioeconomic variables, the group of patients who were employed at the time showed the highest prevalence of taking the exam during pregnancy compared to women who did not work (PR: 2.19; 95% CI 1.00 to 4.87; p: 0.043). Patients that had the pregnancy considered high risk pregnancy (PR: 3.15; 95% CI 1.52 to 6.54; p <0.001), that had prenatal care at MEAC (PR: 2.77; 95% CI 1.48 -5.19; p 0.001), that made all consultations with a physician (PR: 2.95; 95% CI 1.53 to 5.69; p: 0.003), that did not have a health center close to home (PR: 3.22; 95% CI 1.44 to 7.21; p: 0.026) and that knew that the exam could be done during pregnancy (PR: 5.05; 95% CI 2.16 to 11.83; p <0.001) had significantly higher prevalence of having their Pap smear performed during prenatal care. It can be concluded that the frequency of offering and the realization of cervical cytological collection was very low and that it is necessary to conduct awareness programs for health professionals on the importance and safety of performing the prevention of cervical cancer during prenatal visits
publishDate 2016
dc.date.issued.fl_str_mv 2016-02-24
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
status_str publishedVersion
format masterThesis
dc.identifier.uri.fl_str_mv http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=17484
url http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=17484
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal do CearÃ
dc.publisher.program.fl_str_mv Programa de PÃs-GraduaÃÃo em SaÃde PÃblica
dc.publisher.initials.fl_str_mv UFC
dc.publisher.country.fl_str_mv BR
publisher.none.fl_str_mv Universidade Federal do CearÃ
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da UFC
instname:Universidade Federal do Ceará
instacron:UFC
reponame_str Biblioteca Digital de Teses e Dissertações da UFC
collection Biblioteca Digital de Teses e Dissertações da UFC
instname_str Universidade Federal do Ceará
instacron_str UFC
institution UFC
repository.name.fl_str_mv -
repository.mail.fl_str_mv mail@mail.com
_version_ 1643295225061310464